Clinical review: Use of vancomycin in haemodialysis patients

Critical Care

Volumn 6, Issue 4, 2002, Pages 313-316

  Launay Vacher, Vincent ^a   Izzedine, Hassane ^a   Mercadal, Lucile ^a   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Haemodialysis; Vancomycin

Indexed keywords

CREATININE; VANCOMYCIN;

CREATININE CLEARANCE; DIALYSIS MEMBRANE; DISEASE SEVERITY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DIFFUSION; DRUG EXCRETION; DRUG METABOLISM; DRUG USE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; URINARY EXCRETION;

EID: 0036337168     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc1516     Document Type: Review

References (23)

1. Vancomycin therapy in patients with impaired renal function: A nomogram for dosage
2. Vancomycin
3. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: Prospective multicenter randomized study
4. Renal excretion of vancomycin in kidney disease
5. Pharmacokinetics of vancomycin in patients with various degrees of renal function
6. Vancomycin pharmacokinetics in acute renal failure: Preservation of nonrenal clearance
7. A simplified dosing method for initiating vancomycin therapy
8. Vancomycin monitoring: One or two serum levels?
9. Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients
10. Vancomycin ototoxicity and nephrotoxicity. A review
11. Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity incancer patients?
12. Emergence of vancomycin resistance in Staphylococcus aureus
13. Clearance of vancomycin during continuous arteriovenous hemodiafiltration
14. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis
15. Comparison of the effects of three haemodialysis membranes on vancomycin disposition
16. Pharmacokinetics of vancomycin when administered during high flux hemodialysis
17. Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialysers
18. Vancomycin redistribution: Dosing recommendations following high-flux hemodialysis
19. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis
20. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile
21. Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease
22. Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics
23. Dosage recommendation of vancomycin during haemodialysis with highly permeable membranes